In the current study, the natural compound l-CDL, which exerted a potent analgesic effect on alleviating bone cancer pain, significantly attenuated morphine tolerance by antagonizing spinal D2DR at nonnarcotic analgesic doses, and we further explored its underlying mechanism. Here, DRD2 is linked to bone neoplasm.